CHF5074 reduces biomarkers of neuroinflammation in patients with mild cognitive impairment: a 12-week, double-blind, placebo-controlled study.
Ross J, Sharma S, Winston J, Nunez M, Bottini G, Franceschi M, Scarpini E, Frigerio E, Fiorentini F, Fernandez M, Sivilia S, Giardino L, Calza L, Norris D, Cicirello H, Casula D, Imbimbo BP.
Ross J, et al. Among authors: bottini g.
Curr Alzheimer Res. 2013 Sep;10(7):742-53. doi: 10.2174/13892037113149990144.
Curr Alzheimer Res. 2013.
PMID: 23968157
Clinical Trial.